BioSpace News Archive

Artificial Intelligence in pharma refers to the system of interconnected and automated technologies in the biotech industry that can function autonomously, with little or no human intervention.

Temperature is one of the oldest diagnostic parameter and an important indicator of human health and disease, both in the context of medical care and in everyday life

The global market for hepatitis E diagnostic tests is treading a growth path as the prevalence of hepatitis E, especially in resource-poor regions is on the rise.

Photocure ASA announces a highlight from the BLADDR 2020 congress, a poster presentation on new findings from the Nordic Flexible BLC registry, an ongoing prospective multicenter study.

Cullgen Inc. announced that the company’s internal program to develop selective degraders that target key proteins within the TRK family has been published by the Journal of Medicinal Chemistry.

First therapy recommended for full marketing authorization in the EU for eligible patients with confirmed diagnosis of late infantile or early juvenile MLD variants

Arch Biopartners Inc., announced it has dosed the first patient in the Phase II trial of its lead drug LSALT peptide, targeting prevention of acute lung injury, acute kidney injury and other complications caused by inflammation in hospitalized patients with moderate to severe cases of COVID-19.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Dupixent® (dupilumab),

Regulatory News: Aptorum Group Limited (Nasdaq: APM; Euronext Paris: APM) (the “Company”, “Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, today announced it will hold its 2020 annual general meeting of shareholders at its Hong Kong office located at 17/F, Guangdong Investment Tower, 148 Connaught Road Central,

Halo Labs, a life science instrumentation company developing tools for biologics researchers, announced today it is releasing a non-fluorescence version of its revolutionary Aura™ platform.